LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Conditions

• Breast Cancer
• DCIS
• Invasive Duct Carcinoma of Breast

Interventions

• DRUG: LS301-IT 0.025 mg/kg
• DRUG: LS301-IT 0.05 mg/kg
• DRUG: LS301-IT 0.075 mg/kg
• DRUG: LS301-IT 0.1 mg/kg

Sponsor

Integro Theranostics